CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

Clinical trial NCT00211939 · COMPLETED

Trial details

NCT number: NCT00211939
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Calcinosis Arteriosclerosis Hyperparathyroidism, Secondary

Start date: 2005-01-01
Primary completion: 2006-12-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.